The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease.

By Bartolome Celli, C. Côté, J. Marin, C. Casanova, M. Montes de Oca, R. Mendez, V. Pinto Plata, Howard Cabral. New England Journal of Medicine, 2004

4,100 citations recorded by the source corpus.

Subfields: Complementary and alternative medicine, Pulmonary and Respiratory Medicine, Sociology and Political Science

View Paper: https://www.semanticscholar.org/paper/12606ed46f2e1cd6f56b679b445a8fda29690f65

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Pulmonary and Respiratory Medicine

1. D. Parums
2. P. Calverley
3. K. Rabe
4. A. Anzueto
5. Jorgen Vestbo
6. R. Stockley
7. R. Rodríguez-Roisín
8. G. Hagan

In Sociology and Political Science

1. P. Calverley
2. R. Stockley
3. G. Hagan
4. K. Rabe
5. R. Rodríguez-Roisín
6. A. Anzueto
7. Jorgen Vestbo
8. D. Parums

Citations in the corpus

• Persistent Systemic Inflammation is Associated with Poor Clinical Outcomes in COPD: A Novel Phenotype (2012, methodology): “The BODE index was calculated as previously described [23].”
• Evaluation of COPD Longitudinally to Identify Predictive Surrogate End-points (ECLIPSE) (2008, background): “Finally, although FEV1 as well as other measures of lung function can be used for prognostic purposes, the association between mortality and FEV1 is considerably stronger when other measures are added to the predictive equation (10).”
• Quadriceps strength predicts mortality in patients with moderate to severe chronic obstructive pulmonary disease (2006, background): “The endpoint measured was death or lung transplantation and median (range) follow up was 38 (1-54) months.”
• Body mass, fat-free body mass, and prognosis in patients with chronic obstructive pulmonary disease from a random population sample: findings from the Copenhagen City Heart Study. (2006, background): “For these reasons, BMI has been suggested as one of four parameters suitable for staging COPD (6).”
• Body composition and mortality in chronic obstructive pulmonary disease. (2005, background): “On the basis of numerous reports showing an association between BMI and mortality risk in COPD, Celli at al (26) recently proposed that clinical staging for COPD should be based not only on spirometry and resting arterial blood gases, eg, the recent GOLD criteria, but also on BMI, exercise capacity,”
• Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease - 2007 update. (2007, background): “a global score (eg, the BODE index [108]) or identified indi-”
• Characterisation of COPD heterogeneity in the ECLIPSE cohort (2010, methodology): “The BODE index was calculated according to Celli et al [5].”